Suzhou, China · Founded 2014 · In IPO Registration
Developer of original anti-tumor drugs designed for anti-cancer therapeutics. Gen House is based in Suzhou, China and was founded in 2014. Its last reported valuation was $268 million in Jan 2026. It has raised $121 million.
Last reported valuation
$268.3M
Oct 2026
Priced at
—
Total raised
$120.5M
Last round
—
Team — not yet on record
No current team members for Gen House are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Gen House with a free account
·The complete investor list: 23 names
·Watch Gen House: the Monday email on marks, rounds and moves
